SCHEMBL5115410

SCHEMBL5115410

CCC(=O)Nc1cc(Cl)cc(COc2c(Br)cc(CC(F)C(=O)O)cc2Br)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 8/20 0.39
THRA P10827 7/20 0.39
TSHR P16473 1/20 0.37
PTGER1 P34995 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
DHODH Q02127 2/20 0.36
ALDH1A1 P00352 1/20 0.36
SENP5 Q96HI0 1/20 0.36
SENP2 Q9HC62 1/20 0.36
SENP1 Q9P0U3 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
FFAR1 O14842 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722478 0.95 THRB (0.37) THRBTHRATSHRPTGER1SLC1A2
SCHEMBL5119830 0.91 TSHR (0.40) THRBTHRATSHRPTGER1SLC1A2
SCHEMBL5111457 0.90 THRB (0.40) THRBTHRASLC1A2SLC1A1DHODH
SCHEMBL4349711 0.89 THRB (0.40) THRBTHRAPTGER1DHODHSENP5
SCHEMBL5118803 0.88 THRA (0.39) THRBTHRAPTGER1DHODHALDH1A1
SCHEMBL4356850 0.87 THRB (0.50) THRBTHRAMAPTFFAR1
SCHEMBL5722480 0.87 ALDH1A1 (0.37) THRBTHRATSHRPTGER1ALDH1A1
SCHEMBL4931798 0.87 THRB (0.41) THRBTHRADHODHFFAR1
SCHEMBL5119332 0.87 THRB (0.43) THRBTHRASLC1A2SLC1A1DHODH
SCHEMBL5722645 0.86 FFAR1 (0.37) THRBTHRATSHRPTGER1SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRB 4/4885THRA 3/4885TSHR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.